<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T17:57:35Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6416832" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6416832</identifier>
        <datestamp>2019-03-25</datestamp>
        <setSpec>bmcmedgeno</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Med Genomics</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Med Genomics</journal-id>
              <journal-title-group>
                <journal-title>BMC Medical Genomics</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1755-8794</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6416832</article-id>
              <article-id pub-id-type="pmcid">PMC6416832</article-id>
              <article-id pub-id-type="pmc-uid">6416832</article-id>
              <article-id pub-id-type="pmid">30871558</article-id>
              <article-id pub-id-type="pmid">30871558</article-id>
              <article-id pub-id-type="publisher-id">490</article-id>
              <article-id pub-id-type="doi">10.1186/s12920-019-0490-y</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The molecular mechanisms driving physiological changes after long duration space flights revealed by quantitative analysis of human blood proteins</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Kashirina</surname>
                    <given-names>Daria N.</given-names>
                  </name>
                  <address>
                    <email>daryakudryavtseva@mail.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Percy</surname>
                    <given-names>Andrew J.</given-names>
                  </name>
                  <address>
                    <email>info@proteincentre.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pastushkova</surname>
                    <given-names>Liudmila Kh.</given-names>
                  </name>
                  <address>
                    <email>lpastushkova@mail.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Borchers</surname>
                    <given-names>Christoph H.</given-names>
                  </name>
                  <address>
                    <email>christoph@proteincentre.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kireev</surname>
                    <given-names>Kirill S.</given-names>
                  </name>
                  <address>
                    <email>kir-kireev@yandex.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ivanisenko</surname>
                    <given-names>Vladimir A.</given-names>
                  </name>
                  <address>
                    <email>salix@bionet.nsc.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kononikhin</surname>
                    <given-names>Alexey S.</given-names>
                  </name>
                  <address>
                    <email>konoleha@yandex.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nikolaev</surname>
                    <given-names>Eugene N.</given-names>
                  </name>
                  <address>
                    <email>ennikolaev@rambler.ru</email>
                  </address>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Larina</surname>
                    <given-names>Irina M.</given-names>
                  </name>
                  <address>
                    <email>irina.larina@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0390 4822</institution-id><institution-id institution-id-type="GRID">grid.418847.6</institution-id><institution>Institute for Biomedical Problems – Russian Federation State Scientific Research Center of RAS, </institution></institution-wrap>Moscow, Russia </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9465</institution-id><institution-id institution-id-type="GRID">grid.143640.4</institution-id><institution>Genome British Columbia Proteomics Centre, </institution><institution>University of Victoria, </institution></institution-wrap>Victoria, BC Canada </aff>
                <aff id="Aff3"><label>3</label>Yu.A.Gagarin Research and Test Cosmonaut Training Center, Star City, Moscow Region, Russia </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.418953.2</institution-id><institution>Institute of Cytology and Genetics of SB RAS, </institution></institution-wrap>Novosibirsk, Russia </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121896553</institution-id><institution-id institution-id-type="GRID">grid.4605.7</institution-id><institution>Novosibirsk State University, </institution></institution-wrap>Novosibirsk, Russia </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2192 9124</institution-id><institution-id institution-id-type="GRID">grid.4886.2</institution-id><institution>V.L. Talrose Institute for Energy Problems of Chemical Physics, </institution><institution>Russian Academy of Sciences, </institution></institution-wrap>Moscow, Russia </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000000092721542</institution-id><institution-id institution-id-type="GRID">grid.18763.3b</institution-id><institution>Moscow Institute of Physics and Technology, </institution></institution-wrap>Dolgoprudny, Moscow region, Russia </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0555 3608</institution-id><institution-id institution-id-type="GRID">grid.454320.4</institution-id><institution>Skolkovo Institute of Science and Technology, </institution></institution-wrap>Skoltech, Moscow region, Russia </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>3</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>13</day>
                <month>3</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>12</volume>
              <issue>Suppl 2</issue>
              <issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. YO is co-author of one of the articles and review of the article was handled entirely by AB. No other competing interests were declared.</issue-sponsor>
              <elocation-id>45</elocation-id>
              <permissions>
                <copyright-statement>© The Author(s). 2019</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">The conditions of space flight have a significant effect on the physiological processes in the human body, yet the molecular mechanisms driving physiological changes remain unknown.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Blood samples of 18 Russian cosmonauts who had conducted long-duration missions to the International Space Station were collected 30 days before launch and on the first and seventh days after landing.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">A panel of 125 proteins in the blood plasma was quantitated by a well-established and highly regarded targeted mass spectrometry approach. This method involves the monitoring of multiple reactions in conjunction with stable isotope-labeled standards at the University of Victoria - Genome BC Proteomics Centre.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">Reduction of circulating plasma volume during space flight and activation of fluid retention at the final stage of the flight affect the changes in plasma protein concentrations present in the first days after landing. Using an ANOVA approach, it was revealed that only 1 protein (S100A9) reliably responded to space flight conditions. This protein plays an important role in the functioning of the endothelium and can serve as a marker for activation of inflammatory reactions. Concentrations of the proteins of complement, coagulation cascades, and acute phase reactants increase in the blood of cosmonauts as measured the first day after landing. Most of these proteins’ concentrations continue to increase by the 7th day after space flight. Similar dynamics are observed for proteases and their inhibitors. Thus, there is a shift in proteolytic blood systems, which is necessary for the restoration of muscle tissue and maintenance of oncotic homeostasis.</p>
                </sec>
                <sec>
                  <title>Electronic supplementary material</title>
                  <p>The online version of this article (10.1186/s12920-019-0490-y) contains supplementary material, which is available to authorized users.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Cosmonauts</kwd>
                <kwd>Mass spectrometry</kwd>
                <kwd>Blood proteins</kwd>
              </kwd-group>
              <conference xlink:href="http://conf.bionet.nsc.ru/bgrssb2018/en/">
                <conf-name>11th International Multiconference “Bioinformatics of Genome Regulation and Structure\Systems Biology” - BGRS\SB-2018</conf-name>
                <conf-loc>Novosibirsk, Russia</conf-loc>
                <conf-date>20-25 August 2018</conf-date>
              </conference>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par9">The peculiar features of space radiation and microgravity during space flight generate risk for the cardiovascular system (CVS) thus increasing the risks to human space exploration. Space flight has significant influence on cardiovascular system function due to fluid redistribution and modification mechanisms involved in the regulation of blood pressure. Endothelial cells are active functioning elements of the CVS that participate in the factors affecting adaptation to space flight. It was shown that human endothelial cells from the umbilical vein are highly sensitive to microgravity [<xref ref-type="bibr" rid="CR1">1</xref>]. The endothelium carries out barrier functions and is involved in the regulation of vascular tone, hemostasis, immune response, migration of blood cells to the vascular wall, and synthesis of inflammation factors and inhibitors. Thus, endothelial dysfunction can lead to the development of cardiovascular diseases. This dysfunction could also be the cause of the cardiovascular responses in cosmonauts known as cardiovascular disadaptation. However, the molecular mechanisms of physiological changes after space flight remain unknown. Recently, genomic and proteomic approaches have received significant attention. Proteomic methods with biological databases open new opportunities to reveal proteins participating in adaptive and pathological processes [<xref ref-type="bibr" rid="CR2">2</xref>]. We have already analyzed the same set of cosmonauts’ blood proteins [<xref ref-type="bibr" rid="CR3">3</xref>]. There were three distinct groups of proteins: 1) proteins with post-flight protein concentrations remaining stable; 2) proteins whose concentrations recovered slowly; and 3) proteins whose concentrations recovered rapidly to their pre-flight levels. Now we reanalyze this data set to reveal the reason for the decreased concentrations of these proteins with subsequent correlation with states of water and electrolytic exchange in cosmonauts in the final flight period. The previous analysis was aimed at identifying proteins involved in the adaptation process to the conditions of terrestrial gravity, and mainly, the dynamics of proteins’ level recovery were examined by looking at samples collected on the seventh day, while in the current study, the mechanism of changes in protein concentrations from samples taken on the first day after flight was examined.</p>
              <p id="Par10">It is well known, that plasma volume is reduced during spaceflight. Weightlessness exerts substantial effects on fluid redistribution in the human body. Plasma volume reduces by approximately 10–17% within the first day of spaceflight and this level is maintained until the end of mission [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. After returning to normal gravity cardiac stroke volume and arterial pressure falls below pre-flight upright levels [<xref ref-type="bibr" rid="CR6">6</xref>]. It is necessary to restore initial plasma volume so fluid-retaining systems become activated. The volume of circulating blood increases due to modulation of hormones regulating water-salt metabolism, but the synthesis of blood proteins lags behind. Thus, plasma ‘dilution’ occurs where the blood contains less proteins compared with preflight data. In this manuscript, we analyzed results with a correction on plasma ‘dilution.’</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Blood collection</title>
                <p id="Par11">Whole blood samples from eighteen Russian cosmonauts (all male, mean ± SD age: 44 ± 6 years old) were analyzed. All subjects provided written informed consent to participate in the experiment «Proteome» in advance of their long duration (169–199 days) missions on the ISS. The experiment «Proteome» was approved by Biomedicine Ethics Committee of the Russian Federation Scientific Research Center-Institute of Biomedical Problems, Russian Academy of Sciences/Physiology Section of the Russian Bioethics Committee Russian Federation National Commission for UNESCO, and the Human Research Multilateral Review Board, NASA, Houston, TX, USA. Blood samples were collected 30 days before launch (L-30), and on the first (R + 1) and seventh (R + 7) days after landing. Blood was taken by venipuncture from a vein in the cubital fossa. Collection was done in commercial SARSTEDT-Monovette® tubes containing EDTA as the anticoagulant. Blood samples were centrifuged at 2000 g for 15 min at + 4 °C to remove plasma and the supernatant was frozen at − 80 °C until usage.</p>
              </sec>
              <sec id="Sec4">
                <title>Target peptide panel</title>
                <p id="Par12">The target panel for liquid chromatography-mass spectrometric multiple reaction monitoring-based (LC/MRM-MS) analysis comprised proteins functioning in extracellular fluid. The target proteins are classified as high-to-moderate abundance, spanning an approximate concentration range from 33 mg/mL to 44 ng/mL [<xref ref-type="bibr" rid="CR7">7</xref>]. In the MRM-with-SIS-peptide quantitative approach, proteotypic peptides (usually tryptic) serve as molecular representatives of the target proteins. To help with compensation for matrix-induced suppression or variability in LC-MS performance, C-terminal 13C/15 N-labeled peptide analogues were used as internal standards (SIS-peptides). These were synthesized and purified at the University of Victoria - Genome BC Proteomics Centre. The CZE-derived purity of the 142 SIS peptides was 94.2%, on average [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              </sec>
              <sec id="Sec5">
                <title>LC/MRM-MS analysis</title>
                <p id="Par13">All steps of solution and sample preparation, LC/MRM-MS parameters, are described in the article [<xref ref-type="bibr" rid="CR3">3</xref>]. LC/MRM-MS analysis was performed with a Zorbax Eclipse Plus RP-UHPLC column on a 1290 Infinity UPLC system (all from Agilent Technologies) that was interfaced to a triple quadrupole mass spectrometer (Agilent 6490) via Agilent’s Jet Stream™ source, operated in the positive-ion ESI mode. Plasma tryptic digests were analyzed only once. The MRM data was visualized and examined with MassHunter Quantitative Analysis software (version B.07.00; Agilent). Quantitation was done using linear regression analysis, as described previously [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              </sec>
              <sec id="Sec6">
                <title>Bioinformational analysis</title>
                <p id="Par14">Statistical analysis was made with Statistics 7 software. Molecular function, biological processes, and paths were analyzed using DAVID database, PANTHER database, web application AmiGO, and search engine PubMed. The molecular masses and properties of proteins were annotated according to the information available from the UniProt KB database.</p>
              </sec>
            </sec>
            <sec id="Sec7">
              <title>Results and discussion</title>
              <p id="Par15">We obtained a list of all plasma proteins for each cosmonaut. In our data set, 125 plasma proteins were detected and quantitated. Using software Statistics 7 we performed analysis of variance (ANOVA). In the result we identified 19 proteins with statistically significant differences (<italic>p</italic>-value&lt; 0,05) between samples collected at L-30, R + 1, and R + 7 (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Proteins with statistically significant differences (<italic>p</italic>-value&lt; 0,05) between points of blood collection</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Protein name</th><th colspan="3">Means, fmol/μl</th><th colspan="3">p-values</th><th rowspan="2">МW (kDa)</th></tr><tr><th>L-30</th><th>R + 1</th><th>R + 7</th><th>L-30 vs R + 1</th><th>R + 1 vs R + 7</th><th>L-30 vs R + 7</th></tr></thead><tbody><tr><td>78 kDa glucose-regulated protein</td><td>6.3</td><td>4.6</td><td>5.3</td><td><bold>0.031</bold></td><td>0.216</td><td>0.200</td><td>72.3</td></tr><tr><td>Alpha-2-HS-glycoprotein</td><td>134.2</td><td>80.3</td><td>86.3</td><td><bold>0.037</bold></td><td>0.794</td><td>0.215</td><td>39.3</td></tr><tr><td>Apolipoprotein A-II</td><td>5168.8</td><td>4188.9</td><td>4410.8</td><td><bold>0.015</bold></td><td>0.423</td><td><bold>0.038</bold></td><td>11.2</td></tr><tr><td>Apolipoprotein A-IV</td><td>1277.7</td><td>1002.1</td><td>1425.1</td><td>0.067</td><td><bold>0.003</bold></td><td>0.275</td><td>45.4</td></tr><tr><td>Apolipoprotein C-III</td><td>8.1</td><td>6.7</td><td>8.3</td><td>0.121</td><td><bold>0.031</bold></td><td>0.850</td><td>10.9</td></tr><tr><td>Beta-2-microglobulin</td><td>110.6</td><td>96.6</td><td>116.8</td><td><bold>0.024</bold></td><td><bold>0.004</bold></td><td>0.322</td><td>13.7</td></tr><tr><td>Cadherin-5</td><td>16.2</td><td>14.2</td><td>15.7</td><td><bold>0.044</bold></td><td>0.193</td><td>0.635</td><td>87.5</td></tr><tr><td>cDNA FLJ53327</td><td>1007.1</td><td>802.2</td><td>959.2</td><td><bold>0.012</bold></td><td><bold>0.048</bold></td><td>0.535</td><td>77.8</td></tr><tr><td>Cystatin-C</td><td>71.9</td><td>41.9</td><td>49</td><td><bold>0.014</bold></td><td>0.630</td><td>0.218</td><td>15.8</td></tr><tr><td>Fibronectin</td><td>121.8</td><td>100.9</td><td>110.9</td><td><bold>0.044</bold></td><td>0.145</td><td>0.267</td><td>262.6</td></tr><tr><td>Fibulin-1</td><td>139.9</td><td>129.2</td><td>163.8</td><td>0.213</td><td><bold>0.000</bold></td><td><bold>0.021</bold></td><td>77.2</td></tr><tr><td>Gelsolin</td><td>811.6</td><td>611.1</td><td>737.2</td><td><bold>0.001</bold></td><td><bold>0.005</bold></td><td>0.182</td><td>85.7</td></tr><tr><td>Insulin-like growth factor binding protein, acid labile subunit</td><td>155.6</td><td>153.5</td><td>142.5</td><td>0.703</td><td><bold>0.047</bold></td><td><bold>0.014</bold></td><td>66.1</td></tr><tr><td>Lumican</td><td>510.3</td><td>446.9</td><td>528.2</td><td><bold>0.028</bold></td><td><bold>0.001</bold></td><td>0.503</td><td>38.4</td></tr><tr><td>Mannan-binding lectin serine protease 1</td><td>67.4</td><td>59.5</td><td>56.3</td><td>0.063</td><td>0.459</td><td><bold>0.010</bold></td><td>79.2</td></tr><tr><td>Neuropilin-2</td><td>42.7</td><td>41.1</td><td>46.8</td><td>0.432</td><td><bold>0.016</bold></td><td>0.106</td><td>104.9</td></tr><tr><td>Plasma serine protease inhibitor (PAI-3)</td><td>89.9</td><td>91.8</td><td>104.7</td><td>0.783</td><td><bold>0.045</bold></td><td>0.079</td><td>45.7</td></tr><tr><td>Protein S100-A9</td><td>2.7</td><td>6.2</td><td>3.8</td><td><bold>0.039</bold></td><td>0.070</td><td>0.152</td><td>13.2</td></tr><tr><td>Serotransferrin</td><td>9743.3</td><td>8235.4</td><td>8343.3</td><td><bold>0.028</bold></td><td>0.843</td><td><bold>0.030</bold></td><td>77.1</td></tr></tbody></table><table-wrap-foot><p>Note: <italic>p</italic>-values&lt; 0,05 are bold</p></table-wrap-foot></table-wrap></p>
              <p id="Par16">Most of these proteins are decreased at R + 1 except PAI-3 (slight increase) and protein S100-A9 (significant increase) (Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Myeloid-related protein S100A9 is a calcium- and zinc- binding protein, which plays a prominent role in the regulation of inflammatory processes and immune response. It is predominantly found as calprotectin (S100A8/A9), which has a wide array of intra- and extracellular functions. Calprotectin is predominantly expressed in myeloid cells. Its extracellular functions involve proinflammatory, antimicrobial, oxidant-scavenging, and apoptosis-inducing activities. Its proinflammatory activity includes recruitment of leukocytes, promotion of cytokine and chemokine production, and regulation of leukocyte adhesion and migration. Calprotectin also stimulates innate immune cells via binding to pattern recognition receptors such as Toll-like receptor 4 (TLR4) and receptor for advanced glycation end products (AGER). These receptors modulate vascular inflammation and play an important role in atherosclerosis pathogenesis. Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways resulting in the amplification of the proinflammatory cascade and IL-6 secretion. Calprotectin is found in high concentrations at local sites of inflammation or in the serum of patients with inflammatory diseases such as rheumatoid, cystic fibrosis, inflammatory bowel disease, Crohn’s disease, giant cell arteritis, cystic fibrosis, systemic lupus erythematosus, and progressive systemic sclerosis. A transcriptional profiling approach in patients with acute coronary syndromes identified S100A9 as a novel predictor of myocardial infarction [<xref ref-type="bibr" rid="CR9">9</xref>]. Further studies demonstrated that elevated plasma levels of S100A9 heterodimer predict increased risk of first and recurrent cardiovascular events [<xref ref-type="bibr" rid="CR10">10</xref>]. Up-regulation of S100A9 heterodimer is involved in atherosclerosis [<xref ref-type="bibr" rid="CR11">11</xref>]. Thus, S100A9 broadly regulates vascular inflammation and contributes to the biological response to vascular injury [<xref ref-type="bibr" rid="CR12">12</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>The dynamics of changes in concentrations of protein S100-A9, fibulin-1, cystatin-C, and alpha-2-HS-glycoprotein at the points of blood collection: 30 days before launch (L-30), and on the first (R + 1) and seventh (R + 7) days after landing. Notes to figure: *-statistically significant difference (<italic>p</italic>-value&lt; 0,05) compared with L-30; ** - statistically significant difference (p-value&lt; 0,01) compared with R + 1</p></caption><graphic xlink:href="12920_2019_490_Fig1_HTML" id="MO1"/></fig></p>
              <p id="Par17">Consequently, an increased S100A9 level at R + 1 could serve as a marker of activation of proinflammatory reactions or damage of endothelial cells due to landing stress. Endothelium is crucial for human vascular integrity and blood vessel function and its damage causes changes in the vascular wall similar to inflammation. In any case, increased levels of this protein can adversely affect cosmonauts’ vessels, which can have long-term consequences.</p>
              <p id="Par18">Analyzing the dynamics of 19 reliably different proteins, we found that most of these proteins are decreased on the first day after landing compared with L-30 (except for the proteins PAI-3 and S100A9). Compared to R + 1, these proteins were found to have increased at R + 7 (excluding apolipoprotein A-II, serotransferrin, insulin-like growth factor binding protein, and mannan-binding lectin serine protease 1), approaching background levels or remaining just below them. Thus, the contents of these proteins in the plasma were restored. However, the concentration of fibulin-1 (Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1) on the seventh day after landing was increased and significantly differed from both background and R + 1. Fibulin-1 is a fibronectin fiber. As it is able to bind fibrin, it participates in the organization of extracellular matrix and maintenance of hemostasis. In our data set, concentration of fibrin precursors (fibrinogens) was increased by the first and seventh days after landing (Table <xref rid="Tab2" ref-type="table">2</xref>), followed by fibulin-1.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Proteins with increased or stable concentration at R + 1</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Protein name</th><th colspan="3">Means, fmol/μl</th><th rowspan="2">Complement component</th><th rowspan="2">Acute phase proteins</th><th rowspan="2">Proteases</th><th rowspan="2">Protease inhibitors</th></tr><tr><th>L-30</th><th>R + 1</th><th>R + 7</th></tr></thead><tbody><tr><td><bold>Alpha-1-antichymotrypsin</bold></td><td>2392.5</td><td>2411.6</td><td>2473.1</td><td/><td>+</td><td/><td>+</td></tr><tr><td>Apolipoprotein B-100</td><td>474.9</td><td>478.1</td><td>415.9</td><td/><td/><td/><td/></tr><tr><td><bold>Apolipoprotein E</bold></td><td>797.9</td><td>914.5</td><td>915.8</td><td/><td/><td/><td/></tr><tr><td><bold>Beta-2-glycoprotein 1</bold></td><td>3367.2</td><td>3387.3</td><td>3471.1</td><td/><td/><td/><td/></tr><tr><td><bold>C4b-binding protein alpha chain</bold></td><td>208.1</td><td>208.9</td><td>211.1</td><td/><td/><td/><td/></tr><tr><td>Carbonic anhydrase 1</td><td>55.4</td><td>69.9</td><td>56.8</td><td/><td/><td/><td/></tr><tr><td><bold>Ceruloplasmin</bold></td><td>2158.3</td><td>2182.9</td><td>2292.2</td><td/><td>+</td><td/><td/></tr><tr><td>Coagulation factor XI</td><td>46.9</td><td>49.3</td><td>46.2</td><td>+</td><td/><td>+</td><td/></tr><tr><td><bold>Complement C2</bold></td><td>108.4</td><td>109.5</td><td>110.0</td><td>+</td><td/><td>+</td><td/></tr><tr><td><bold>Complement C3</bold></td><td>5936.4</td><td>5986.7</td><td>6141.2</td><td>+</td><td>+</td><td>+</td><td/></tr><tr><td><bold>Complement C4-B</bold></td><td>1639.5</td><td>1651.7</td><td>1691.3</td><td>+</td><td/><td>+</td><td/></tr><tr><td>Complement component C9</td><td>215.0</td><td>252.3</td><td>247.2</td><td>+</td><td>+</td><td/><td/></tr><tr><td><bold>Fibrinogen alpha chain</bold></td><td>6781.9</td><td>7651.4</td><td>7726.8</td><td>+</td><td>+</td><td/><td/></tr><tr><td><bold>Fibrinogen beta chain</bold></td><td>419.0</td><td>423.5</td><td>428.7</td><td>+</td><td>+</td><td/><td/></tr><tr><td><bold>Fibrinogen gamma chain</bold></td><td>426.4</td><td>480.3</td><td>490.1</td><td>+</td><td>+</td><td/><td/></tr><tr><td><bold>Fibrinopeptide A</bold></td><td>1469.0</td><td>1593.3</td><td>1663.9</td><td/><td/><td/><td/></tr><tr><td><bold>Haptoglobin</bold></td><td>18,033.4</td><td>19,230.8</td><td>19,612.7</td><td/><td>+</td><td>+</td><td/></tr><tr><td>Hemoglobin subunit alpha</td><td>2628.5</td><td>3248.1</td><td>2452.5</td><td/><td/><td/><td/></tr><tr><td>Insulin-like growth factor-binding protein complex acid labile subunit</td><td>143.3</td><td>156.9</td><td>148.1</td><td/><td/><td/><td/></tr><tr><td>Leucine-rich alpha-2-glycoprotein</td><td>271.2</td><td>321.2</td><td>308.2</td><td/><td/><td/><td/></tr><tr><td>Lipopolysaccharide-binding protein</td><td>121.1</td><td>126.8</td><td>119.4</td><td/><td>+</td><td/><td/></tr><tr><td>MRNA for apolipoprotein E</td><td>677.4</td><td>790.8</td><td>778.8</td><td/><td/><td/><td/></tr><tr><td><bold>Plasma serine protease inhibitor (PAI-3)</bold></td><td>89.9</td><td>91.8</td><td>104.7</td><td>+</td><td/><td/><td>+</td></tr><tr><td><bold>Protein AMBP</bold></td><td>926.0</td><td>1007.6</td><td>1080.5</td><td/><td/><td/><td>+</td></tr><tr><td>Protein S100-A9</td><td>2.7</td><td>6.2</td><td>3.8</td><td/><td/><td/><td/></tr><tr><td>Serum paraoxonase/lactonase 3</td><td>20.0</td><td>20.2</td><td>18.8</td><td/><td/><td/><td/></tr><tr><td>Thyroxine-binding globulin</td><td>166.9</td><td>173.6</td><td>171.6</td><td/><td/><td/><td>+</td></tr><tr><td><bold>Vitamin D-binding protein</bold></td><td>3222.1</td><td>3301.9</td><td>3306.5</td><td/><td/><td/><td/></tr><tr><td><bold>Vitamin K-dependent protein C</bold></td><td>40.4</td><td>40.6</td><td>41.5</td><td>+</td><td/><td>+</td><td/></tr><tr><td><bold>Vitronectin</bold></td><td>325.1</td><td>326.4</td><td>352.1</td><td/><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>Note: proteins which continue to increase concentration at R + 7 are bold</p></table-wrap-foot></table-wrap></p>
              <p id="Par19">Analyzing concentrations of blood proteins, we took into consideration that plasma volume is reduced by approximately 10–17% within the first day of spaceflight. Total red blood cell mass decreases by approximately 10% within 1 week in space [<xref ref-type="bibr" rid="CR5">5</xref>]. Then the amount of proteins is reduced to maintain osmotic homeostasis established under conditions of weightlessness. When the hypovolemic cosmonauts return to upright position in gravity, cardiac stroke volume and arterial pressure falls below pre-flight upright levels [<xref ref-type="bibr" rid="CR6">6</xref>], and fluid-retaining systems become activated. Compared with pre-flight levels, on the landing day urinary ADH levels increase almost threefold, plasma renin activity increases almost fourfold, plasma aldosterone levels increase by 50%, and plasma atrial natriuretic peptide levels decrease by 33% [<xref ref-type="bibr" rid="CR13">13</xref>]. Also, to prevent reduction in the extracellular fluid volume the cosmonauts are administered water-salt supplements before landing to activate water retention mechanisms and improve body water balance in the post-landing period [<xref ref-type="bibr" rid="CR14">14</xref>]. Fluid intake is relatively high on landing day, and urine volume is reduced compared with pre-flight values. Fluid metabolism appears to normalize within 1 week after returning from short-term space flight [<xref ref-type="bibr" rid="CR13">13</xref>]. Long-term space flights may require longer recovery periods. However, changes in protein concentrations can also be caused by other space flight factors, including emotional stress, circadian rhythm shift and overloads during the landing stage.</p>
              <p id="Par20">Thus, in the early post-flight period blood is ‘diluted’ by extra fluid and this leads to a decrease in the concentration of plasma proteins at R + 1 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). In addition, in this experiment we observed a decrease in concentration of the major protein in the blood plasma, albumin, although this decrease did not rise to the level of significance. Still, it is necessary to resupply proteins in plasma to recover colloid-oncotic pressure. We supposed that synthesis of protease inhibitors such as PAI-3 is activated after space flight to deactivate proteolysis. It was shown that protease inhibitors are activated in response to hypoproteinemia. Hypoproteinemia due to sepsis leads to a 2–5 fold decrease of the activity of endogenous proteinases while the activity of protease inhibitors, alpha 1-antichymotrypsin and an acid-stable inhibitor of trypsin, was found to be higher by 20–30% in blood plasma [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
              <p id="Par21">Despite the plasma ‘dilution’, it is possible to distinguish proteins that decrease more than others do. Two proteins, cystatin-C and alpha-2-HS-glycoprotein, which are cysteine protease inhibitors, decrease their concentration at R + 1 (by 41.8 and 40% respectively) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Thus, the dynamics of protease inhibitors is ambiguous, but changes in this system can be clearly traced.</p>
              <p id="Par22">Blood ‘dilution’ due to space flight makes the detection of proteins with increased concentration more difficult. Therefore, proteins whose concentration increased on the first day after landing or did not decrease with the majority of cosmonauts’ blood proteins, although not rising to the level of significance, were of interest. From the total number of identified proteins (125) we analyzed 30 proteins with increased or stable concentration at R + 1 (Table <xref rid="Tab2" ref-type="table">2</xref>).</p>
              <p id="Par23">Using web application AmiGO and DAVID database we performed functional analysis of these proteins. Complement and coagulation cascades are significantly more represented pathways (<italic>p</italic> &lt; 0.05 with consideration of Benjamini-Hochberg correction for multiple comparisons). The complement system is a cascade of proteolytic enzymes. The principal function of the complement system is protection of the host from infection/inflammation by recruiting (chemotaxis) and enhancing phagocytosis by innate immune cells, leading to lysis of the target cells. It is a part of both the innate and adaptive immune responses. The complement system can potentially damage host cells as well, so when the complement system is stimulated by proteases, it could damage endothelium.</p>
              <p id="Par24">Ten proteins with increased or stable concentrations at R + 1 participate in complement and coagulation cascades. Eight of these proteins (Complement C2, C3, C4B, fibrinogen alpha, beta and gamma chain, vitamin K-dependent protein C, and PAI-3) are increased at R + 1 and continue to increase at R + 7 (Table <xref rid="Tab2" ref-type="table">2</xref>). Thus, we can suppose that increased synthesis of these proteins is induced by space flight.</p>
              <p id="Par25">Five proteins of the complement and coagulation cascades (coagulation factor XI, complement C2, C3, C4B, and protein C) are proteases. Thus, five proteases are increased at R + 1 after space flight; all of them are serine-type endopeptidases.</p>
              <p id="Par26">Together with serine proteases, serine protease inhibitors such as α1-antichymotrypsin, protein AMBP, thyroxine-binding globulin, and PAI-3 were increased at R + 1 (Table <xref rid="Tab2" ref-type="table">2</xref>). In addition, proteins participating in negative regulation of endopeptidase activity (vitronectin and complement C3) were increased or unchanged. PAI-3 was increased at R + 1 and continued to increase at R + 7 (Table <xref rid="Tab1" ref-type="table">1</xref>) reaching significance, as detected by ANOVA. Thus, we can suppose that increased synthesis of this protein is induced by space flight.</p>
              <p id="Par27">Thus, a large portion of proteins with decreased or increased concentration at R + 1 were proteases and protease inhibitors. Redistribution of the amounts of proteases and their inhibitors has physiological value. It is necessary to satisfy the requirement of an organism for new proteins. Proteases cleave old proteins and generate amino acids which are used for rapid building of new proteins that are necessary for adaptation processes. It is known that the concentrations of free amino acids (lysine, threonine, valine, leucine, isoleucine, and phenylalanine) are decreased in blood after space flight [<xref ref-type="bibr" rid="CR16">16</xref>]. Therefore, a blood supply with amino acids produced by proteases represents an acute adaptive reaction. In the first days after spaceflight an organism needs plastic resources (proteins) for muscle tissue reconstruction and possibly blood oncotic pressure recovery.</p>
              <p id="Par28">Concentrations of 9 acute-phase proteins in the plasma were increased in our data set. Seven of them (complement C3, 1-antichymotrypsin, fibrinogen α, β and γ chain, ceruloplasmin, and haptoglobin) continued to increase in concentration by R + 7 (Table <xref rid="Tab2" ref-type="table">2</xref>). Acute-phase proteins are a class of proteins in which plasma concentrations increase (positive acute-phase proteins) or decrease (negative acute-phase proteins) in response to inflammation or injury. Several of them have antiprotease activity. It is worth saying that some negative acute-phase proteins (serotransferrin and alpha-2-HS-glycoprotein) were significantly decreased (Table <xref rid="Tab1" ref-type="table">1</xref>).</p>
              <p id="Par29">A number of studies confirm an increase of acute phase proteins after space flight. Kaur and Simons [<xref ref-type="bibr" rid="CR17">17</xref>] showed that levels of the lipopolysaccharide binding protein in the plasma of 20 crew members, 3–4 h and 15 days after landing, were increased. Fibrinogen concentration was significantly increased (by 13.2%) on the first day after space flight [<xref ref-type="bibr" rid="CR18">18</xref>]. Even after short-duration space flights lasting 4–7 days, the phenomenon of fibrinogenemia (an increased level of fibrinogen in the blood) was demonstrated [<xref ref-type="bibr" rid="CR19">19</xref>]. Stein et al. showed an increased rate of fibrinogen synthesis on the first day after the end of a 16-day flight [<xref ref-type="bibr" rid="CR20">20</xref>]. However, increased concentration of fibrinogen is observed not only in acute inflammatory processes in the body, but also during stress [<xref ref-type="bibr" rid="CR21">21</xref>] and at decreased levels of physical activity [<xref ref-type="bibr" rid="CR22">22</xref>]. It is possible the day of landing is associated with short-term metabolic stress, as suggested by the confirmed increased synthesis of fibrinogen and release of cortisol and interleukin-6 [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
              <p id="Par30">There are other works confirming our results. After 49-days of spaceflight, increased levels of α-2 globulins, ceruloplasmin, and haptoglobin were demonstrated, whose concentrations were maximal on the 14th day of the re-adaptation period [<xref ref-type="bibr" rid="CR24">24</xref>]. Significant shifts of β-globulin fractions were observed: transferrin was decreased and C3 and C4 complement factors were increased on the first post-flight day. In our study, similar changes were detected. The authors point out the development of the acute phase response after the end of the flight. This response could be due to both the accelerations from descent and landing as well as the conditions associated with a return to terrestrial gravity.</p>
              <p id="Par31">In all mammals, the synthesis of acute phase proteins is regulated by inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor (TNF). For example, IL-6 plays an important role in the regulation of haptoglobin, fibrinogen, and alpha-1-anti-chymotrypsin. There is evidence that human endothelial cells have increased secretion of IL-6 after exposure to spaceflight conditions [<xref ref-type="bibr" rid="CR25">25</xref>]. Stein and Schluter found that urinary IL-6 and cortisol excretion were increased on the 1st day of spaceflight, suggesting an acute-phase response to a stress during adaptation to the space environment [<xref ref-type="bibr" rid="CR26">26</xref>]. On the day of landing, there was also a significant increase in IL-6 levels in urine in some astronauts [<xref ref-type="bibr" rid="CR27">27</xref>]. However, excretion of cortisol in urine corresponded to the background level, which lowers the probability that emotional stress plays a role in the induction of the acute phase response. The question of whether or not the acute phase response develops after the landing remains to be answered.</p>
              <p id="Par32">The increasing S100A9 concentration could be attributed to induction of IL-6 synthesis. It has been shown that the above-described S100A9 protein is able to induce IL-6 production in human gingival fibroblasts [<xref ref-type="bibr" rid="CR28">28</xref>] and in human endothelial cells pretreated with AGE albumin [<xref ref-type="bibr" rid="CR29">29</xref>]. There is evidence that in addition to participating in the inflammatory response, S100A8 and S100A9 proteins are involved in angiogenesis due to their ability to enhance proliferation, migration, and formation of tubular structures by endothelial cells [<xref ref-type="bibr" rid="CR30">30</xref>]. It is known that angiogenesis is enhanced by inflammation. Thus, the S100A9 protein could be the mechanism of angiogenesis activation occurring in inflammation.</p>
              <p id="Par33">Some of the proteins with increased concentrations at R + 1 also contribute to angiogenesis. Leucine-rich alpha-2-glycoprotein positively regulates proliferation of endothelial cells. Complement C3 stimulates the production of vascular endothelial growth factor (VEGF) and vitronectin positively regulates the VEGF signal pathway. VEGF stimulates angiogenesis, vascular growth, endothelial cells growth, as well as their proliferation and migration, both necessary for angiogenesis. In the tissues of skeletal muscles, the most important factor of angiogenesis is VEGF. The secretion of VEGF from muscle cells is stimulated by various factors including muscle contraction. Therefore, the concentration of VEGF increases markedly in muscle activity, which triggers angiogenesis. Interestingly, our data indicate that during the first day after landing, angiogenesis processes are activated, related to the restoration of muscle mass and the need to ensure their adequate blood supply. In the work [<xref ref-type="bibr" rid="CR31">31</xref>] it is confirmed that skeletal muscle training has a strong angiogenic effect. It is possible that after space flight the hypotrophic muscles are reloaded and activation of inflammation at a low level occurs. Accordingly, it can be assumed that during the acute period of re-adaptation, an inflammatory response is initiated as activation of pro-inflammatory reactions is physiologically necessary to trigger neovascularization in the muscles that are hypotrophic after landing.</p>
              <p id="Par34">The data obtained by new analysis confirm the involvement of pathways that regulate the activities of proteases, natural immunity, lipid metabolism, and coagulation cascades that were determined in a previous analysis [<xref ref-type="bibr" rid="CR3">3</xref>]. In addition, the article explains the dynamics of the most extensive group of proteins described in a previous article and whose concentrations recovered rapidly to their pre-flight levels [<xref ref-type="bibr" rid="CR3">3</xref>]. It was assumed that changes in the subjects’ blood concentrations are transitory and may be attributable to the influence of the final stage of the flight, including such factors as emotional stress and overloads during the landing stage. In the light of new data, it is believed that the dynamics of these proteins are also associated with changes in the volume of circulating plasma.</p>
            </sec>
            <sec id="Sec8">
              <title>Conclusion</title>
              <p id="Par35">Reduction of circulating plasma volume during space flight, and subsequent activation of fluid retention at the final stage of flight - affect the changes in plasma protein concentrations in the first days after landing. Using the ANOVA approach, it was revealed that only 1 protein reliably responded to the space flight conditions described herein - S100A9. This protein plays an important role in the functioning of endothelium and can serve as a marker for the activation of inflammatory reactions. There are increases in the concentrations of the proteins of complement and the coagulation cascade, as well as an increase in the acute phase response, in the blood of cosmonauts on the first day after landing. Most of these proteins’ concentrations continue to increase by the 7th day after landing. Similar dynamics are observed for proteases and their inhibitors. Thus, there is a shift in proteolytic blood systems, which is necessary for the restoration of muscle tissue and maintenance of oncotic homeostasis. We assume that during the acute period of cosmonauts’ re-adaptation, the load of hypotrophic muscles under conditions of terrestrial gravity initiates an inflammatory response and activation of angiogenesis processes. Consequently, using the proteomic method of studying the blood of cosmonauts to expand the understanding of the mechanisms of the adaptive process will perhaps serve as the basis for the development of preventive measures.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Additional file</title>
              <sec id="Sec9">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12920_2019_490_MOESM1_ESM.docx">
                      <label>Additional file 1</label>
                      <caption>
                        <p>: <bold>Figure S1.</bold> Box &amp; Whisker plots of 19 proteins with statistically significant differences between points of blood collection. (DOCX 521 kb)</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>ANOVA</term>
                  <def>
                    <p id="Par5">Analysis of variance</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CVS</term>
                  <def>
                    <p id="Par6">Cardiovascular system</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PAI-3</term>
                  <def>
                    <p id="Par7">Plasma serine protease inhibitor</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VEGF</term>
                  <def>
                    <p id="Par8">Vascular endothelial growth factor</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ack>
              <p>The authors are grateful for Conference Organizing Committee BGRS\SB-2018, ICG SB RAS (budget project 0324-2018-0017).</p>
              <p>We thank Gene L. Dowell, MD, MS, University of Texas Medical Branch and the reviewers for science discussion and valuable comments.</p>
              <sec id="FPar1">
                <title>Funding</title>
                <p id="Par36">The research and publication costs were covered by RFBR grant № 18–34-00524 (KDN) and Russian Ministry of Science and Education (project 28.12487.2018/12.1).</p>
              </sec>
              <sec id="FPar2" sec-type="data-availability">
                <title>Availability of data and materials</title>
                <p id="Par37">Not applicable.</p>
              </sec>
              <sec id="FPar3">
                <title>About this supplement</title>
                <p id="Par38">This article has been published as part of <italic>BMC Medical Genomics Volume 12 Supplement 2, 2019: Selected articles from BGRS\SB-2018: medical genomics.</italic> The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcmedgenomics.biomedcentral.com/articles/supplements/volume-12-supplement-2">https://bmcmedgenomics.biomedcentral.com/articles/supplements/volume-12-supplement-2</ext-link>.</p>
              </sec>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>Conceived and designed the experiments: LIM, ENN, PLH. Performed the experiments: PAJ, BCH, PLH, KKS. Analyzed the data: KDN, LIM, IVA. Wrote the paper: KDN, KKS, LIM. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="COI-statement">
              <sec id="FPar4">
                <title>Ethics approval and consent to participate</title>
                <p>All members of the main and backup crews provided written informed consent to participate in the experiment «Proteome» in advance of their missions on the ISS. The experiment «Proteome» was approved by Biomedicine Ethics Committee of IBMP RAS/Physiology Section of the Russian Bioethics Committee Russian Federation National Commission for UNESCO and Human Research Multilateral Review Board, NASA, Houston, Tx, USA.</p>
              </sec>
              <sec id="FPar5">
                <title>Consent for publication</title>
                <p>All members of the main and backup crews provided written informed consent to participate in the experiment «Proteome» in advance of their missions on the ISS. The experiment «Proteome» was approved by Biomedicine Ethics Committee of IBMP RAS/Physiology Section of the Russian Bioethics Committee Russian Federation National Commission for UNESCO and Human Research Multilateral Review Board, NASA, Houston, Tx, USA.</p>
              </sec>
              <sec id="FPar6">
                <title>Competing interests</title>
                <p>The authors declare that they have no competing interests.</p>
              </sec>
              <sec id="FPar7">
                <title>Publisher’s Note</title>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </sec>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maier</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Cialdai</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Monici</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Morbidelli</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of microgravity and hypergravity on endothelial cells</article-title>
                  <source>Biomed Res Int</source>
                  <year>2015</year>
                  <volume>2015</volume>
                  <fpage>434803</fpage>
                  <pub-id pub-id-type="doi">10.1155/2015/434803</pub-id>
                  <pub-id pub-id-type="pmid">25654101</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Binder</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wirth</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Arakelyan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lembcke</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Tiys</surname>
                      <given-names>ES</given-names>
                    </name>
                    <name>
                      <surname>Ivanisenko</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Kolchanov</surname>
                      <given-names>NA</given-names>
                    </name>
                    <name>
                      <surname>Kononikhin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Popov</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Nikolaev</surname>
                      <given-names>EN</given-names>
                    </name>
                    <name>
                      <surname>Pastushkova</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Larina</surname>
                      <given-names>IM</given-names>
                    </name>
                  </person-group>
                  <article-title>Time-course human urine proteomics in space-flight simulation experiments</article-title>
                  <source>BMC Genomics</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <issue>Suppl 12</issue>
                  <fpage>S2</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2164-15-S12-S2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Larina</surname>
                      <given-names>IM</given-names>
                    </name>
                    <name>
                      <surname>Percy</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Borcher</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Nosovsky</surname>
                      <given-names>AМ</given-names>
                    </name>
                    <name>
                      <surname>Grigoriev</surname>
                      <given-names>AI</given-names>
                    </name>
                    <name>
                      <surname>Nikolaev</surname>
                      <given-names>EN</given-names>
                    </name>
                  </person-group>
                  <article-title>Protein expression changes caused by spaceflight as measured for 18 Russian cosmonauts</article-title>
                  <source>Sci Rep</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>8142</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-08432-w</pub-id>
                  <pub-id pub-id-type="pmid">28811532</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drummer</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gerzer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Baisch</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Body fluid regulation in micro-gravity differs from that on Earth: an overview</article-title>
                  <source>Pflugers Arch</source>
                  <year>2000</year>
                  <volume>441</volume>
                  <issue>2-3Suppl</issue>
                  <fpage>R66</fpage>
                  <lpage>R72</lpage>
                  <pub-id pub-id-type="doi">10.1007/s004240000335</pub-id>
                  <pub-id pub-id-type="pmid">11200983</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Watenpaugh</surname>
                      <given-names>DE</given-names>
                    </name>
                  </person-group>
                  <article-title>Fluid volume control during short-term spaceflight and implications for human performance</article-title>
                  <source>J ExpBiol</source>
                  <year>2001</year>
                  <volume>204</volume>
                  <issue>Pt.18</issue>
                  <fpage>3209</fpage>
                  <lpage>3215</lpage>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buckey</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Lane</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>BD</given-names>
                    </name>
                    <name>
                      <surname>Watenpaugh</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Wright</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Moore</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Gaffney</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Blomqvist</surname>
                      <given-names>CG</given-names>
                    </name>
                  </person-group>
                  <article-title>Orthostatic intolerance after spaceflight</article-title>
                  <source>J Appl Physiol</source>
                  <year>1996</year>
                  <volume>81</volume>
                  <fpage>7</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1996.81.1.7</pub-id>
                  <pub-id pub-id-type="pmid">8828642</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Percy</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Chambers</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hardie</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Borchers</surname>
                      <given-names>CH</given-names>
                    </name>
                  </person-group>
                  <article-title>Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility</article-title>
                  <source>Biochim Biophys Acta</source>
                  <year>2014</year>
                  <volume>1844</volume>
                  <fpage>917</fpage>
                  <lpage>926</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbapap.2013.06.008</pub-id>
                  <pub-id pub-id-type="pmid">23806606</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kuzyk</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Parker</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Domanski</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Borchers</surname>
                      <given-names>CH</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of MRM-based assays for the absolute quantitation of plasma proteins</article-title>
                  <source>Methods Mol Biol</source>
                  <year>2013</year>
                  <volume>1023</volume>
                  <fpage>53</fpage>
                  <lpage>82</lpage>
                  <pub-id pub-id-type="doi">10.1007/978-1-4614-7209-4_4</pub-id>
                  <pub-id pub-id-type="pmid">23765619</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Healy</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Pickard</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Pradhan</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Croce</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Sakuma</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zago</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Garasic</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Damokosh</surname>
                      <given-names>AI</given-names>
                    </name>
                    <name>
                      <surname>Dowie</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Poisson</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lillie</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Libby</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Ridker</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Simon</surname>
                      <given-names>DI</given-names>
                    </name>
                  </person-group>
                  <article-title>Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events</article-title>
                  <source>Circulation.</source>
                  <year>2006</year>
                  <volume>113</volume>
                  <issue>19</issue>
                  <fpage>2278</fpage>
                  <lpage>2284</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.607333</pub-id>
                  <pub-id pub-id-type="pmid">16682612</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Altwegg</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Neidhart</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hersberger</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Eberli</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Corti</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Roffi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sutsch</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Gay</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>von Eckardstein</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wischnewsky</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Luscher</surname>
                      <given-names>TF</given-names>
                    </name>
                    <name>
                      <surname>Maier</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes</article-title>
                  <source>Eur Heart J</source>
                  <year>2007</year>
                  <volume>28</volume>
                  <issue>8</issue>
                  <fpage>941</fpage>
                  <lpage>948</lpage>
                  <pub-id pub-id-type="doi">10.1093/eurheartj/ehm078</pub-id>
                  <pub-id pub-id-type="pmid">17387139</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cagnin</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Biscuola</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Patuzzo</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Trabetti</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pasquali</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Laveder</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Faggian</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Iafrancesco</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mazzucco</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pignatti</surname>
                      <given-names>PF</given-names>
                    </name>
                    <name>
                      <surname>Lanfranchi</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries</article-title>
                  <source>BMC Genomics</source>
                  <year>2009</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>13</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2164-10-13</pub-id>
                  <pub-id pub-id-type="pmid">19134193</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Croce</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Myeloid-related protein-8/14 is critical for the biological response to vascular injury</article-title>
                  <source>Circulation.</source>
                  <year>2009</year>
                  <volume>120</volume>
                  <issue>5</issue>
                  <fpage>427</fpage>
                  <lpage>436</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.814582</pub-id>
                  <pub-id pub-id-type="pmid">19620505</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leach</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Alfrey</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Suki</surname>
                      <given-names>WN</given-names>
                    </name>
                    <name>
                      <surname>Leonard</surname>
                      <given-names>JI</given-names>
                    </name>
                    <name>
                      <surname>Rambaut</surname>
                      <given-names>PC</given-names>
                    </name>
                    <name>
                      <surname>Inners</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Lane</surname>
                      <given-names>HW</given-names>
                    </name>
                    <name>
                      <surname>Krauhs</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of body fluid compartments during short-term spaceflight</article-title>
                  <source>J Appl Physiol</source>
                  <year>1996</year>
                  <volume>81</volume>
                  <fpage>105</fpage>
                  <lpage>116</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1996.81.1.105</pub-id>
                  <pub-id pub-id-type="pmid">8828652</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grigor'ev</surname>
                      <given-names>AI</given-names>
                    </name>
                    <name>
                      <surname>Noskov</surname>
                      <given-names>VB</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of effectiveness of water-salt supplement in the long-duration “MIR” missions</article-title>
                  <source>Aviakosm Ekolog Med</source>
                  <year>2001</year>
                  <volume>35</volume>
                  <issue>5</issue>
                  <fpage>11</fpage>
                  <lpage>15</lpage>
                  <?supplied-pmid 11840863?>
                  <pub-id pub-id-type="pmid">11840863</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Belova</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Ogloblina</surname>
                      <given-names>OG</given-names>
                    </name>
                    <name>
                      <surname>Satalkin</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Diugeev</surname>
                      <given-names>AN</given-names>
                    </name>
                    <name>
                      <surname>Fomin</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Kashina</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Kukharchuk</surname>
                      <given-names>VV</given-names>
                    </name>
                  </person-group>
                  <article-title>Imbalance in the proteinase-inhibitor system in obstetric sepsis and septic shock</article-title>
                  <source>Klin Lab Diagn</source>
                  <year>2003</year>
                  <volume>7</volume>
                  <fpage>13</fpage>
                  <lpage>16</lpage>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Popov</surname>
                      <given-names>IG</given-names>
                    </name>
                    <name>
                      <surname>Lackevich</surname>
                      <given-names>AA</given-names>
                    </name>
                  </person-group>
                  <article-title>Amino acids in the blood of cosmonauts before and after a 211-day flight</article-title>
                  <source>Cosmic Biol Aerospace Med</source>
                  <year>1984</year>
                  <volume>18</volume>
                  <issue>2</issue>
                  <fpage>26</fpage>
                  <lpage>33</lpage>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaur</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Simons</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Kapadia</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Ott</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Pierson</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of spaceflight on ability of monocytes to respond to endotoxins of gram-negative bacteria</article-title>
                  <source>Clin Vaccine Immunol</source>
                  <year>2008</year>
                  <volume>15</volume>
                  <issue>10</issue>
                  <fpage>1523</fpage>
                  <lpage>1528</lpage>
                  <pub-id pub-id-type="doi">10.1128/CVI.00065-08</pub-id>
                  <pub-id pub-id-type="pmid">18768671</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <mixed-citation publication-type="other">Kuzichkin DS, Morukov BV, Markin AA, Krivitzyna ZA, Juravlyova OA. Cosmonauts hemostasis system indices after long-term and short-term space flights. 17th IAA Humans in Space Symposium.2009:75.</mixed-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fomin</surname>
                      <given-names>AN</given-names>
                    </name>
                  </person-group>
                  <article-title>Fibrinogen of blood during 7-day water immersion and short-duration space flight</article-title>
                  <source>Cosmic Biol Aerospace Med.</source>
                  <year>1981</year>
                  <volume>15</volume>
                  <issue>5</issue>
                  <fpage>83</fpage>
                  <lpage>85</lpage>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stein</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Schluter</surname>
                      <given-names>MD</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma protein synthesis after spaceflight</article-title>
                  <source>Aviat Space Environ Med</source>
                  <year>2006</year>
                  <volume>77</volume>
                  <issue>7</issue>
                  <fpage>745</fpage>
                  <lpage>748</lpage>
                  <?supplied-pmid 16856362?>
                  <pub-id pub-id-type="pmid">16856362</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McKenzie</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Celander</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Guest</surname>
                      <given-names>MM</given-names>
                    </name>
                  </person-group>
                  <article-title>Fibrinogen titer as an indicator of physiologic stability</article-title>
                  <source>Am J Physiol.</source>
                  <year>1963</year>
                  <volume>204</volume>
                  <fpage>42</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajplegacy.1963.204.1.42</pub-id>
                  <pub-id pub-id-type="pmid">13932083</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <mixed-citation publication-type="other">Kozlov AA, Berkovich AL, Kachalova ND, Sergeeva EV, Prostakova TM. A manual for laboratory technicians on methods of studying plasma hemostasis. Rus Acad Med Sci. 2006;24.</mixed-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stein</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Leskiw</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Schluter</surname>
                      <given-names>MD</given-names>
                    </name>
                  </person-group>
                  <article-title>Diet and nitrogen metabolism during spaceflight on the shuttle</article-title>
                  <source>J Appl Physiol</source>
                  <year>1996</year>
                  <volume>81</volume>
                  <issue>1</issue>
                  <fpage>82</fpage>
                  <lpage>97</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1996.81.1.82</pub-id>
                  <pub-id pub-id-type="pmid">8828650</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Larina</surname>
                      <given-names>ON</given-names>
                    </name>
                  </person-group>
                  <article-title>Protein composition of the blood plasma of cosmonauts after long orbital flights</article-title>
                  <source>Space Biol Aerospace Med</source>
                  <year>1992</year>
                  <volume>26</volume>
                  <issue>3</issue>
                  <fpage>67</fpage>
                  <lpage>69</lpage>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muid</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Froemming</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Nawawi</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Interleukin-6 and intercellular cell adhesion molecule-1 expression remains elevated in revived live endothelial cells following spaceflight</article-title>
                  <source>Malays J Pathol</source>
                  <year>2013</year>
                  <volume>35</volume>
                  <issue>2</issue>
                  <fpage>165</fpage>
                  <lpage>176</lpage>
                  <?supplied-pmid 24362480?>
                  <pub-id pub-id-type="pmid">24362480</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stein</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Schluter</surname>
                      <given-names>MD</given-names>
                    </name>
                  </person-group>
                  <article-title>Excretion of IL-6 by astronauts during spaceflight</article-title>
                  <source>Am J Phys</source>
                  <year>1994</year>
                  <volume>266</volume>
                  <fpage>E448</fpage>
                  <lpage>E452</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpcell.1994.266.2.C448</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crucian</surname>
                      <given-names>BE</given-names>
                    </name>
                    <name>
                      <surname>Zwart</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Uchakin</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Quiriarte</surname>
                      <given-names>HD</given-names>
                    </name>
                    <name>
                      <surname>Pierson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sams</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight</article-title>
                  <source>J Interf Cytokine Res</source>
                  <year>2014</year>
                  <volume>34</volume>
                  <issue>10</issue>
                  <fpage>778</fpage>
                  <lpage>786</lpage>
                  <pub-id pub-id-type="doi">10.1089/jir.2013.0129</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nishikawa</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Kajiura</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Lew</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Kido</surname>
                      <given-names>JI</given-names>
                    </name>
                    <name>
                      <surname>Nagata</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Naruishi</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Calprotectin induces IL-6 and MCP-1 production via toll-like receptor 4 signaling in human gingival fibroblasts</article-title>
                  <source>J Cell Physiol</source>
                  <year>2017</year>
                  <volume>232</volume>
                  <issue>7</issue>
                  <fpage>1862</fpage>
                  <lpage>1871</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcp.25724</pub-id>
                  <pub-id pub-id-type="pmid">27925202</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ehlermann</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Eggers</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bierhaus</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Most</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Weichenhan</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Greten</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Nawroth</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Katus</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>Remppis</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products</article-title>
                  <source>Cardiovasc Diabetol.</source>
                  <year>2006</year>
                  <volume>30</volume>
                  <fpage>5</fpage>
                  <lpage>6</lpage>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Jia</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?</article-title>
                  <source>Mediat Inflamm</source>
                  <year>2012</year>
                  <volume>2012</volume>
                  <fpage>248574</fpage>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gliemann</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Olesen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Biensø</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>Akerstrom</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Nyberg</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lindqvist</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bangsbo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hellsten</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Resveratrol modulates the angiogenic response to exercise training in skeletal muscles of aged men</article-title>
                  <source>Am J Physiol Heart Circ Physiol</source>
                  <year>2014</year>
                  <volume>307</volume>
                  <issue>8</issue>
                  <fpage>H1111</fpage>
                  <lpage>H1119</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpheart.00168.2014</pub-id>
                  <pub-id pub-id-type="pmid">25128170</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
